Bluebird Sickle Cell Gene Therapy Hangs In Balance

Company Probes Causes Of Blood Cancers

 
• By Alaric DeArment
  
Sickle cell anemia, 3D illustration showing blood vessel with normal and deformated crescent-like red blood cells
Bluebird is looking into potential causes of two cases of hematological cancers in its study of LentiGlobin for sickle cell disease • Source: Shutterstock
Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

SpotifyApple PodcastsWebsite

More from Business

More from Scrip